0001213900-24-021743.txt : 20240312 0001213900-24-021743.hdr.sgml : 20240312 20240312134618 ACCESSION NUMBER: 0001213900-24-021743 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240306 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240312 DATE AS OF CHANGE: 20240312 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INSPIRE VETERINARY PARTNERS, INC. CENTRAL INDEX KEY: 0001939365 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE SERVICES [0700] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 854359258 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41792 FILM NUMBER: 24741396 BUSINESS ADDRESS: STREET 1: 780 LYNNHAVEN PKWY #400 CITY: VIRGINIA BEACH STATE: VA ZIP: 23452 BUSINESS PHONE: (757) 288-3088 MAIL ADDRESS: STREET 1: 780 LYNNHAVEN PKWY #400 CITY: VIRGINIA BEACH STATE: VA ZIP: 23452 8-K 1 ea0201326-8k_inspire.htm CURRENT REPORT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 7, 2024 (March 6, 2024)

INSPIRE VETERINARY PARTNERS, INC.

(Exact name of registrant as specified in its charter)

Nevada		001-41792		85-4359258
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

780 Lynnhaven Parkway, Suite 400

Virginia Beach, VA

23452

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (757) 734-5464

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Class A Common Stock, par value $0.0001		IVP		Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry into a Material Definitive Agreement.

Consulting Agreement

On March 6, 2024, Inspire Veterinary Partners, Inc. (“Inspire” or the “Company”) entered into a consulting agreement (the “Consulting Agreement”) with Charles “Chuck” Keiser, DVM, an experienced professional of veterinary medicine and the business of veterinary medicine, and a former member of the board of directors of the Company, pursuant to which Inspire agreed to compensate Dr. Keiser for certain consulting services that he has provided to the Company relating to veterinary medicine business support and other related activities.

As consideration for Dr. Keiser’s consulting services to the Company, Inspire agreed to issue to Dr. Kesier $151,695.60 worth of restricted shares of Class A common stock of the Company, par value $0.0001 per share, which resulted in the issuance of 1,865,875 shares of Class A common stock based on the closing price of $0.0813 per share on the last trading day immediately prior to the date of the Consulting Agreement, as quoted on The Nasdaq Capital Market. The Consulting Agreement will terminate upon delivery of the shares to Dr. Keiser. The Consulting Agreement contains certain non-disclosure and confidentiality provisions applicable to Dr. Keiser for the benefit of the Company.

The foregoing description of the Consulting Agreement is qualified in its entirety by reference to the Consulting Agreement, a copy of which is attached hereto as Exhibit 10.1, and which is incorporated herein by reference.

General Release

On March 6, 2024, Inspire entered into a general release agreement (the “General Release Agreement”) with Kenneth Seth Lundquist, DVM, Charles “Chuck” Keiser, DVM, and Don I. Williamson, Jr. DVM, and the Estate of Gregory Armstrong (each, a “Releasor” and collectively, the “Releasors”), pursuant to which the Company agreed to issue to each Releasor $5,000 worth of restricted shares of Class A common stock of the Company, par value $0.0001 per share, which resulted in the issuance of 61,501 shares of Class A common stock to each Releasor, based on the closing price of $0.0813 per share on the last trading day immediately prior to the date of the General Release Agreement, as quoted on The Nasdaq Capital Market. As partial consideration for the issuance of the shares pursuant to the General Release Agreement, each Releasor agreed to release Inspire from all potential, pending, or alleged claims, issues or complaints, whether asserted or which could be asserted by the Releasors against the Company, including any such claims, issues or complaints arising from or in connection with Inspire’s previous acquisition from the Releasors of their ownership interest in Kauai Veterinary Clinic, Inc., located in Lihue, Hawaii, and associated real estate.

The foregoing description of the General Release Agreement is qualified in its entirety by reference to the General Release Agreement, a copy of which is attached hereto as Exhibit 10.2, and which is incorporated herein by reference.

Item 3.02 Unregistered Sales of Equity Securities.

The information contained in Item 1.01 of this Current Report on Form 8-K under the captions “Consulting Agreement” and “General Release Agreement” is incorporated herein by reference into this Item 3.02.

1

Inspire issued the restricted shares of Class A common stock to Dr. Keiser as set forth in the Consulting Agreement, and to the Releasors as set forth in the General Release Agreement, pursuant to privately negotiated transactions exempt from registration pursuant to Rule 506(b) of Regulation D under the Securities Act of 1933, as amended. Inspire did not receive any proceeds with respect to the issuance of the shares to Dr. Keiser or the Releasors.

This Current Report on Form 8-K shall not constitute an offer to sell or a solicitation of an offer to buy any shares of Class A common stock of the Company or any other securities of the Company in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

Item. 9.01. Financial Statements and Exhibits

Exhibit No.		Description
10.1		Consulting Agreement, dated March 6, 2024, between Inspire Veterinary Partners, Inc. and Charles “Chuck” Keiser, DVM
10.2		General Release Agreement, dated March 6, 2024, between Inspire Veterinary Partners, Inc. and the Releasors party thereto
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: March 12, 2024	INSPIRE VETERINARY PARTNERS, INC.

	By:	/s/ Kimball Carr
	Name:	Kimball Carr
	Title:	Chair, President and Chief Executive Officer

3

EX-10.1 2 ea0201326ex10-1_inspire.htm CONSULTING AGREEMENT, DATED MARCH 6, 2024, BETWEEN INSPIRE VETERINARY PARTNERS, INC. AND CHARLES "CHUCK" KEISER, DVM

Exhibit 10.1

CONSULTING AGREEMENT

This Agreement dated as of the 6^th of March 2024 (the “Agreement”), between Inspire Veterinary Partners, Inc., a Delaware corporation, located at 2324 Valle Rio Way, Virginia Beach, VA 23456 (“Inspire”) and Charles “Chuck” Keiser, DVM, whose principal business address is 3468 Stanford Road, Danville, KY 40422 (“Consultant”).

WHEREAS, the Consultant is an experienced professional of veterinary medicine and the veterinary medicine business; and

WHEREAS, the Consultant has performed consulting services for the Company relating to veterinary medicine business support and other related activities as directed by the Company;

NOW, THEREFORE, in consideration of the premises and the mutual covenants set forth herein and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, and intending to be bound hereby, the parties hereto agree as follows:

1.

Consultant’s Services. The Consultant has provided to the Company professional consulting services in the area of veterinary medicine business support (“Consulting Services”) as requested and directed by the Company.

2.

Consideration. In consideration for the Consulting Services performed by the Consultant under this Agreement, the Company will issue to the Consultant shares of Class A common stock, $0.0001 par value per share, of the Company (the “Class A Common Stock”) in an amount equal to ONE HUNDRED FIFTY ONE THOUSAND SIX HUNDRED AND NINETY FIVE DOLLARS AND SIXTY CENTS ($151,695.60), determined as the closing price per share of Class A Common Stock quoted on The Nasdaq Capital Market on the last trading day immediately prior to the date of this Agreement. The Company will use commercially reasonable best efforts to issue and delivery to the Consultant or his designee the Class A Common Stock within five (5) business days of execution of this Agreement. The Consultant acknowledges and agrees that the sale of the Class A Common Stock will be consummated as a privately negotiated transaction exempt from registration pursuant to Rule 506(b) of Regulation D under the Securities Act of 1933, as amended (the “Securities Act”), resulting in the issuance of restricted book-entry shares to the Consultant. The Consultant acknowledges and agrees that (i) the Class A Common Stock have not been registered under the Securities Act, and will be issued to the Consultant in reliance upon an exemption from the registration requirements of the Securities Act; (ii) the Class A Common Stock must be held indefinitely, unless they are later registered under the Securities Act or unless an exemption from registration is otherwise available under Rule 144 promulgated under the Securities Act (“Rule 144”) or other applicable law, and that the Company has no obligation to register the Class A Common Stock; (iii) the Class A Common Stock shall not be offered, sold, transferred, pledged, or otherwise disposed of without registration under the Securities Act and applicable state securities laws or an opinion of counsel reasonably acceptable to the Company that such registration is not required; and (iv) the Class A Common Stock shall bear a restrictive Rule 144 legend and that the Class A Common Stock shall maintain such legend until such legend may be removed pursuant to applicable state and federal securities laws;

3.

Expenses. The Company will not be responsible for any costs or expenses incurred by the Consultant relating to the provision of Consulting Services, the issuance, beneficial ownership or disposition of the Class A Common Stock or otherwise arising out of, or in connection with, this Agreement.

1

4.

Notices. All notices and other communications shall be in writing and shall be deemed to have been duly given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered via e-mail or other electronic or digital format at the email address set forth below at or prior to 5:30 p.m. (New York City time) on a business day, (b) the next business day after the date of transmission, if such notice or communication is delivered via e-mail or other electronic or digital format on a day that is not a business day or later than 5:30 p.m. (New York City time) on any business day, (c) the second (2nd) business day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (d) upon actual receipt by the party to whom such notice is required to be given:

If to the Company,

Inspire Veterinary Partners, Inc.

780 Lynnhaven Parkway, Suite 400

Virginia Beach, Virginia 23452

Telephone Number: (757) 734-5464

Email: kcarr@inspirevet.com and rfrank@inspirevet.com

Attention: Kimball Carr and Richard Frank

With a copy (which shall not constitute notice) to:

The Crone Law Group, PC

420 Lexington Avenue, Suite 2446

New York, New York 10170

Telephone Number: (646) 861-7891

Email: mcrone@cronelawgroup.com and jlaxague@cronelawgroup.com

Attention: Mark E. Crone, Esq. and Joe Laxague, Esq.

If to the Subscriber,

Charles “Chuck” Keiser, DVM

3468 Stanford Road

Danville, Kentucky 40422

Telephone Number:

Email: ckeiserdvm@bhcteam.com

Attention: Charles “Chuck” Keiser, DVM

5.

Termination. This Agreement shall remain in effect until terminated pursuant to the terms of this agreement. Either party may terminate this agreement at any time without cause and without incurring any additional obligation, liability or penalty upon five (5) days’ notice to the other party. This Agreement will terminate upon delivery of the shares of Class A Common Stock to the Consultant pursuant to this Agreement, provided that Sections 3 through 9 shall survive termination of this Agreement.

6.

Confidentiality. The Consultant, for himself and his agents, covenant and agree that they will not at any time, except in performance of their obligations to the Company hereunder or with the prior written consent of the Company, directly or indirectly, disclose any secret or confidential information that they may learn or have learned by reason of their association with the Company or any of its subsidiaries and affiliates. The term “confidential information” includes information not previously disclosed to the public or to the trade by the Company’s management, or otherwise in the public domain, with respect to the Company’s, or any of its affiliates’ or subsidiaries’ products, facilities, applications and methods, trade secrets and other intellectual property, systems, procedures, manuals, confidential reports, product price lists, customer lists, technical information, financial information (including the revenues, costs or profits associated with any of the Company’s products or services), business plans, prospects or opportunities.

7.

General Release. The Consultant, for himself and his agents, for valuable consideration, receipt of which is acknowledged, on behalf of himself and his heirs, executors, trustees, legal representatives, administrators, successors, assigns, and agents, past and present, expressly and forever discharges and releases the Company and its past and present predecessors, successors, parents, subsidiaries, affiliates, assigns, stockholders, attorneys, officers, directors, agents, representatives, employees, and insurers, and their respective heirs, executors, administrators, successors, assigns, stockholders, attorneys, officers, directors, agents, representatives, and employees, as well as any and all of their insurers (each a “Released Party” and collectively, “Released Parties”), of and from all claims demands, causes of action, fees and liabilities of any kind whatsoever, whether known or unknown, which the Consultant ever had, now have, or have may against the Company or any Released Party, under the laws of any jurisdiction, by reason of any act, omission, transaction, practice, plan, policy, procedure, conduct, occurrence, or other matter, including, without limitation, all claims which have been, could have been or might be asserted. It is the specific intention of the Parties to this General Release Agreement that this General Release Agreement releases any and all claims by the Consultant against the Company and any of the other Released Parties.

2

8.

Further Assurances. The Consultant agrees to cooperate fully and to execute any and all supplemental documents and to take additional actions that may be necessary or appropriate to give full force and effect to the basic terms and intent of this Release Agreement and which are not inconsistent with its terms.

9.

Miscellaneous.

a.

Severability. If a court of competent jurisdiction determines that any term or provision hereof is invalid or unenforceable, (a) the remaining terms and provisions hereof shall be unimpaired and (b) such court shall have the authority to replace such invalid or unenforceable term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision.

b.

Entire Agreement. This Agreement represents the entire agreement of the parties and shall supersede any and all previous contracts, arrangements or understandings between the Company and the Consultant. The Agreement may be amended at any time by mutual written agreement of the parties hereto.

c.

Construction. This General Release Agreement shall be construed and enforced in accordance with the laws of the State of New York without regard to the principles of conflicts of law. Additionally, any action to enforce the terms of this General Release Agreement shall be commenced exclusively in the federal or state courts in New York County in the City and State of New York. The Parties consent to the exclusive jurisdiction of the federal and state courts in New York County, agree not to seek to transfer or remove the action to another court, waive any claim under the doctrine of forum non conveniens, and WAIVE THEIR RIGHT TO A TRIAL BY JURY.

d.

Successors. This Agreement shall be binding upon and inure to the benefit of, and shall be enforceable by the Consultant and the Company, their respective heirs, executors, administrators and assigns.

e.

Headings. The headings of sections herein are included solely for convenience of reference and shall not control the meaning or interpretation of any of the provisions of this Agreement.

f.

Counterparts. This Agreement may be executed by either of the parties hereto in counterparts, each of which shall be deemed to be an original, but all such counterparts shall together constitute one and the same instrument.

[Signature page follows]

3

IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed as of the day and year first above written.

The Consultant

/s/ C. H. Keiser, DVM
Charles “Chuck” Keiser, DVM
Date:

	The Company

	Inspire Veterinary Partners, Inc.

	By:	/s/ Kimball Carr
	Name:	Kimball Carr
	Title:	Chair, President and Chief Executive Officer

4

EX-10.2 3 ea0201326ex10-2_inspire.htm GENERAL RELEASE AGREEMENT, DATED MARCH 6, 2024, BETWEEN INSPIRE VETERINARY PARTNERS, INC. AND THE RELEASORS PARTY THERETO

Exhibit 10.2

GENERAL RELEASE AGREEMENT

This Agreement dated as of the 6^th day of March 2024 (the “General Release Agreement”), between Inspire Veterinary Partners, Inc., a Nevada corporation, located at 80 Lynnhaven Parkway, Suite 400, Virginia Beach, Virginia 23452 (the “Company”) and (i) Gregory Armstrong, (ii) Kenneth Seth Lundquist, DVM, (iii) Charles “Chuck” Keiser, DVM, and (iv) Don I. Williamson, Jr. DVM (each, a “Releasor” and collectively, the “Releasors”).

WHEREAS, reference is made to that certain “Master Agreement” dated February 17, 2021 (the “Master Agreement”) by and among the Company, the Releasors and KVC Properties LLC, a Hawaii limited liability company; and

WHEREAS, reference is made to that certain binding letter of intent (the “Letter of Intent”, dated October 21, 2022, by and among the Releasors and the Company, pertaining to the matters set forth therein with respect to the Master Agreement.

WHEREAS, the Releasors and the Company (the “Parties”) wish to settle and resolve all potential, pending, or alleged claims, issues or complaints, whether asserted or which could be asserted by the Releasors, and further, to resolve any and all other potential disputes and claims that exist or that may exist among the Parties, and intend that the full terms and conditions of such agreement be set forth in this general release agreement (the “General Release Agreement”); and

WHEREAS, the Company denies any wrongdoing in connection with the Master Agreement and the Letter of Intent, and is entering into this General Release Agreement solely to avoid the expense and inconvenience of proceedings, and the Releasors acknowledges this is the resolution of a disputed matter and does not constitute the acknowledgement of any wrongdoing or liability;

NOW, THEREFORE, in consideration of the premises and the mutual covenants set forth herein and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, and intending to be bound hereby, the Releasors, severally and not jointly, and the Company agree as follows:

1. In return for the covenants and promises contained hereinafter, the Company will issue to the Releasors, in full and final settlement, the number of shares of Class A common stock, $0.0001 par value per share, of the Company (the “Class A Common Stock”), equal to the in the amounts set forth next to each Releasor’s name under the caption “Share Amount” set forth in Exhibit A hereto divided by the closing price per share of Class A Common Stock quoted on The Nasdaq Capital Market on the last trading day immediately prior to the date of this General Release Agreement;

2. Issuance of the Shares will be made by the Company within three (3) business days of the Company’s receipt of fully executed counterparts of the General Release Agreement from each of the Releasors;

3. The Releasors acknowledge and agree that the execution and delivery of counterpart signature pages of the General Release Agreement from each of the Releasors is and shall be a condition precedent of the effectiveness of the General Release Agreement;

4. Each Releasor acknowledges and agrees, severally and not jointly, that the sale of the Class A Common Stock will be consummated as a privately negotiated transaction exempt from registration pursuant to Rule 506(b) of Regulation D under the Securities Act of 1933, as amended (the “Securities Act”), resulting in the issuance of restricted book-entry shares to the Releasors. Each Releasor acknowledges and agrees that (i) the Class A Common Stock have not been registered under the Securities Act, and will be issued to the Releasors in reliance upon an exemption from the registration requirements of the Securities Act; (ii) the Class A Common Stock must be held indefinitely, unless they are later registered under the Securities Act or unless an exemption from registration is otherwise available under Rule 144 promulgated under the Securities Act (“Rule 144”) or other applicable law, and that the Company has no obligation to register the Class A Common Stock; (iii) the Class A Common Stock shall not be offered, sold, transferred, pledged, or otherwise disposed of without registration under the Securities Act and applicable state securities laws or an opinion of counsel reasonably acceptable to the Company that such registration is not required; and (iv) the Class A Common Stock shall bear a restrictive Rule 144 legend and that the Class A Common Stock shall maintain such legend until such legend may be removed pursuant to applicable state and federal securities laws;

1

5. Each Releasor agrees that he and his agents shall keep all information within their possession and control relating to this General Release Agreement and the settlement of these claims and potential claims (the “Confidential Information”) strictly non-public and confidential and will not disclose or request or induce any other person or entity to disclose any Confidential Information to any person or entity without the prior written consent of the Company except to the extent disclosure is required by order issued by a court of law or governmental agency. Any disclosure to any person or entity inconsistent with the provisions of this paragraph shall be deemed a material violation of the terms of this General Release Agreement and will result in irreparable harm to the Company and its affiliates and successors.

6. Each Releasor acknowledges and agrees that the confidentiality provisions of Paragraph 5 above are bargained for consideration required by the Company as an inducement to enter into this settlement.

7. Each Releasor, for valuable consideration, receipt of which is acknowledged, on behalf of himself and his heirs, executors, trustees, legal representatives, administrators, successors, assigns, and agents, past and present, expressly and forever discharges and releases the Company and its past and present predecessors, successors, parents, subsidiaries, affiliates, assigns, stockholders, attorneys, officers, directors, agents, representatives, employees, and insurers, and their respective heirs, executors, administrators, successors, assigns, stockholders, attorneys, officers, directors, agents, representatives, and employees, as well as any and all of their insurers (each a “Released Party” and collectively, “Released Parties”), of and from all claims demands, causes of action, fees and liabilities of any kind whatsoever, whether known or unknown, which the Releasors ever had, now have, or have may against the Company or any Released Party, under the laws of any jurisdiction, by reason of any act, omission, transaction, practice, plan, policy, procedure, conduct, occurrence, or other matter, including, without limitation, all claims which have been, could have been or might be asserted. It is the specific intention of the Parties to this General Release Agreement that this General Release Agreement releases any and all claims by each Releasor against the Company and any of the other Released Parties.

8. Each Releasor acknowledges and agrees that this General Release Agreement is not intended, and shall not be construed, as an admission by the Company or any Released Party that any of the Company or any Released Party has violated any federal, state or local law (statutory or decisional), ordinance or regulation, breached any contract, agreement, promise or policy, or committed any wrong whatsoever against any Releasor.

9. Each Releasor represents and warrants, severally and not jointly, that the claims released hereby are not the subject of any lien, complaint, or claim, and that he has full authority to enter into this General Release Agreement and settle all matters specified herein, and to resolve any and all claims on behalf of any heir, devisee, trustee, or beneficiaries, born or unborn, that now exist or that might be brought in the future. The warranties of this General Release Agreement shall survive the execution and performance thereof.

10. Each Releasor has executed this General Release Agreement voluntarily and for reasons of his own, and in doing so, does not and has not relied upon any statement or promise by any other party, except those expressly set forth in this General Release Agreement. Each Releasor specifically acknowledges and represents that he has consulted with and reviewed General Release Agreement with his attorney(s).

11. Each Releasor understands and agrees that if any issuance of Class A Common Stock to such Releasor referred to in Paragraph 1 is subsequently determined to be taxable, any such taxes are to be such Releasor’s sole responsibility and the Company shall not have any liability or other responsibility with respect thereto.

12. In the event that any provision of this General Release Agreement shall be found by any court, government, or self-regulatory agency, for whatever reason, to be unenforceable, that provision shall be severed from the Release, with all other provisions remaining fully in force.

13. Any failure by the Company to pursue any breach of any provision of this General Release Agreement shall not constitute a waiver of any other provision or any future breach of this Release. Should any litigation result regarding this General Release Agreement, the prevailing party in such litigation shall be entitled to their costs and reasonable attorney’s fees incurred in such litigation.

2

14. This General Release Agreement may not be changed orally.

15. This General Release Agreement shall be construed and enforced in accordance with the laws of the State of New York without regard to the principles of conflicts of law. Additionally, any action to enforce the terms of this General Release Agreement shall be commenced exclusively in the federal or state courts in New York County in the City and State of New York. The Parties consent to the exclusive jurisdiction of the federal and state courts in New York County, agree not to seek to transfer or remove the action to another court, waive any claim under the doctrine of forum non conveniens, and WAIVE THEIR RIGHT TO A TRIAL BY JURY.

16. This General Release Agreement may be executed in counterparts and all counterparts taken together shall constitute the General Release Agreement. The Parties further agree to accept digital signatures as though they were originals.

17. Employee agrees to cooperate fully and to execute any and all supplemental documents and to take additional actions that may be necessary or appropriate to give full force and effect to the basic terms and intent of this General Release Agreement and which are not inconsistent with its terms.

[Signature page follows]

3

IN WITNESS WHEREOF, the parties hereto have approved and executed this General Release Agreement as of the dates set forth below:

Releasors

/s/ Gregory Armstrong
Gregory Armstrong
Date: March 6, 2024

/s/ Kenneth Seth Lundquist, DVM
Kenneth Seth Lundquist, DVM
Date: March 6, 2024

/s/ Charles “Chuck” Keiser, DVM
Charles “Chuck” Keiser, DVM
Date: March 6, 2024

/s/ Don I. Williamson, Jr. DVM
Don I. Williamson, Jr. DVM
Date: March 6, 2024

	The Company

	Inspire Veterinary Partners, Inc.

	By:	/s/ Kimball Carr
	Name:	Kimball Carr
	Title:	Chair, President and Chief Executive Officer

4

Exhibit A

Releasor		Share Amount
Gregory Armstrong		$	5,000
Kenneth Seth Lundquist, DVM		$	5,000
Charles “Chuck” Keiser, DVM		$	5,000
Don I. Williamson, Jr. DVM		$	5,000

5

EX-101.SCH 4 ivp-20240306.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 ivp-20240306_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 ivp-20240306_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT

Cover	Mar. 06, 2024
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Mar. 06, 2024
Entity File Number	001-41792
Entity Registrant Name	INSPIRE VETERINARY PARTNERS, INC.
Entity Central Index Key	0001939365
Entity Tax Identification Number	85-4359258
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	780 Lynnhaven Parkway, Suite 400
Entity Address, City or Town	Virginia Beach
Entity Address, State or Province	VA
Entity Address, Postal Zip Code	23452
City Area Code	757
Local Phone Number	734-5464
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Class A Common Stock, par value $0.0001
Trading Symbol	IVP
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false

EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://inspirevet.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ea0201326-8k_inspire.htm ivp-20240306.xsd ivp-20240306_lab.xml ivp-20240306_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ea0201326-8k_inspire.htm": { "nsprefix": "IVP", "nsuri": "http://inspirevet.com/20240306", "dts": { "inline": { "local": [ "ea0201326-8k_inspire.htm" ] }, "schema": { "local": [ "ivp-20240306.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "ivp-20240306_lab.xml" ] }, "presentationLink": { "local": [ "ivp-20240306_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://inspirevet.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-03-06", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea0201326-8k_inspire.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-06", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea0201326-8k_inspire.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 16 0001213900-24-021743-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-24-021743-xbrl.zip M4$L#!!0 ( ,AM;%@>0Y2HCA8 Z" 8 96$P,C Q,S(V+3AK7VEN MR*RE)FR\^$ E9 M:"B2 4A;RJ]_9P!2(BG26R0[R_'P\[O=[O_VWGCJ8>%(.BMGR9GWJ>>U NW]S.NDX6&L M4._]Q;(0:*3+!;MF7LEP9EBL4:E76GDT+D;-=H[@_XX\[EFL?536?^>.9LRC M!$D4V6>?7[_,=QS;8[97'"UVSNE94%EJ%669,\^K]BD9QR9ID' M9,B\0]*G,W9 YN;\D/1.U#\N*[7.Y;OA;[63U\?'%_ 7]I\4B_>L7*]=PB O MXX.[# =W?SJ-QK+2(VHW]R\9J!7T'OX[GC';A/][IQ:]NIQ02[('4&I$*'5M MD,*B Z0$M7JVR>9G;'%9 2>V7]^OMYKW)]MZ!3P^N:Q>!OY TX='#R!1NQQ. MJ6#RLG:IO)^F(=6S!Y YP9YP/T%,?R?((:4JS4BV ^Q(9! FW&#V*"SQ-NOLSS M^76Q7JGDVTH-CLHQLH]N*%4OH@U6\^V5EJ2U6HZ.%OL ;HX)F'B95._1F1Y( M-4M"7XB:^@ZFRE/R:[<86DAI+LU\\-8#?_ R+_G,M1CZ@*"5&&'=DG1\$30$ MA92\#X*!JS$D!AYXIK D4X,/'RX?:Z]Z'])9O4O6 IW)J!.^270IVGKX+&!?C*6^S34_ MP:J23)PQ*GW!VH'U'4"1D%3X*D8?::43UX:<13\8O"KSR 96WB+9")@V"&Z- MH5A3Z3KU'+%Z^^"Q)[N70C/2X@FSG1FW[VCS3GXD&TTA&[Z.#C_)QL#T5I:F M+3YP=D=EJ-O.Y7)';N@;9U1<,3J8%'EX[%S4,2 MO PIZ??5U7N< XJ2?X$)!I[FV__YI=JJ'.J1!7]&1E".#2%CX"$)-U;@OI-- M.'@U:E(Y)&B016KQ*WAD@!]A H8_;K_K]T;=$S(<'8^ZPZ/RN+WM!H?=SKM! M;]3K#LEQ_X1T_^[\<=Q_W26=\[=O>\-A[[S_%+WX0.448CK/@?HGI4Z)U #K M[&^]Y:>1Z>GYX"TYDBZUE.(:/J !\Z6Q1)DKO/FE\>ZF M,Y_^XWY8 &1Y%"*(MA$! C4 GO%LR0"."IC5]L_"/-!NP?=_H@,NA?G@]%3 MZ/*%+Z1/;8]X#E0T,%[50ZW6B2-(M;ECOM /G$G.FS(LY ON<6BZ.S>FU 8_ M=&QXQ)D00"*-)Q+$$X@#\0J.:L!<1WAD)_S-*,Q.3'H$0C3@FU"OF?GB (!] M^RT5QI3L%@CJ-ME)VM&KA!U=*/S3U> HW:"Z\_F7T?!L]\.)]2"#TND'-![O MP 3J,R@[->EB ?UG=IK!Q3H3M;Q:/AA72X\KPP9?_"!&J(46$%=E3&8X0N5R M#H@/,8K 3$^^G>4E=4PS8%=<8B;(P]@Q7;A_M>SFR:O%1[/^Z9'>,JVMJ.SJ M^7:O/[SH#;KD?7?4'?3ZQX-_R,7Q8-3O#H8%TNMW2ID^]6E[W85[?"KK MQE=),Z/1J&C!0>PUBXUZ<[_6W+NG;.$/D>5O4^6P7=[O*,>#N-H!*"W(OX"D MII*IN66&2]D^H$Y)N[/\6I$^W'0.L7&0WYB*/ M35,P*8._WD P4$UWCWPZ_>M-]77S^O-CLR&9#49=XVZ^O;M7(6\6MCVE$)62 M"RH^W= %#-KGX' :E9.G96Y&#DW=CHS7W\2%Y\7]ANOW]@$ M,U?-15D)H.0]QR%Q2EXQ:DPS&%=8RY&=IHU).?QS<0'(%/QZ!@CN_-G_^.<[ M<_#Y+=_$P!)M1D>W#Z,[OD,5O@E0E* /)O_LT4W W0L'8@WK(W>S@QIST7WW M;\.[MG?-3<@SUF)$FG7PZ+5ZHWE?H/NM@:%@>!CSNP(TE;O4(FS.#-_CUY@* M@+F1R>? !+>1V2 #0*0$9?JT\_YVG/PJ _6?7_9JU=U#"<4LYDX=FQ%;H;L" M0EO+1VB1HX)1L 43F/&0C-M:0C5,N:$S/P::V49YW7CU9V?/YOO_/"R/NC+* M:!M1,ZS"[-O. ,8'65"A$ESPDVH?":8S(7JQ M!9P6SNHYB\IP\6'3N= M2N%?7T+,L\BW.U,&& 7E*CK"@S@82OHG=R7*J5=-=?'&R7ZN M/[X[_51S7W]AHX=E-Z.K=6/'L1BUU3:[J"-/[4;4F]=1.?9W&XW#NYPYXHP5 MBU-ELSFV!OW.&;&.$S>R\HQ;6K1>-VK-P"(3B\VXQKQ3W26=TP&IU2LE*!B' MA@HX;0XU_;2^9[:^2F!]0X@0#= !^^HM3!$P3UCIIO=>?AG2\]?=6G6\<=-; M[T/4[AK?IMVM.IV;!;W.,+IJ@Q:KM8C=Q79V+*VN42GIDC\-[TG]N[FY[[LOD0-L?EM&B)TOFA$>G^_ MF;#:,(NUG7&P^^I>MJDK_+3.']DZ=].MLR>ES\2=-OJE^?=[/JQ4)O.'+4@\ MPD;7>A2UU-8/9:EU5FSL& ^PU*#"5BUUJVF_)>\C"%W'U$Q 5.ZN[RHE5?1- MN2#&!HX\3YB\[;7.VU/*^4*V&^&Q[UN!'W2_2(C/#RI][T:4V)8 M5,K;,O*W]3:KLU^U[IZ;J1I;)AR\N)&6N)@;]< M5&MC95D9T_3D_;^++_[?O2^/71%.MA.=?'?S[0[:,3DF.&&#/(:>8WPJ$)<* M07VK=)DW[.$!GI4)=[U")OJ?C$O.]XW7>)LWJVB?"8D?&"&&I1!VI] @_/U!;' M^&)+CDL" @9LC82O"/CO&P]0A3-S<0&&2F*R";?U;O](4KC2#!=G$AEA?>JH M3G:PX.ZA2@R'A;DZ+.#B80%<48O@]=JX6,NM$TP[S[2DC+ =ZZW1+CTACMUL M&X)?3;W@$;=Q.R*&M!#1YMO=# DE#;0>VR(3UGJM*G5TG70['8R%\^=P_TUC M]._7!J*>\-GZYIG4OD1LM5$)0M!6=@BZ+9X_D65.;K$UW(R1,-R<,ER^MD Z M!;-D%D1Q8):VHV(Z7S)5"IH-EF'QQANNXCQ]IA\%I=JR%MCX#8>F48%L&!&\ M$>R:2Z@'QDYM S/3U%!7PV"V&J\;,JDPI5Z -=,#RC#VWJ'+ XIK47=I36$K M<86=CY8=U\??TK65RK]'5P/CG_Y\XUF3K(Y$5;5Z=[;D.W5!JQS.\YW4CYS$ M3SVI'SG)OZF3^C^"?'!AZ; M@5@J5=+%0W&XO\8AE(2KG>0$81E7^S*/KP13R='2!C=%J4Z$P]HD5=[N.+;T M+9Q85EW'73R;M9<$?MJ^2::W>VZ3V%'M NGIZ\3(>X:BM"D(]X(*SV9"%G(] MVR@APMVKU2J'04GUJWJ(LS1.I\'+ $ %+U\0%?HIG*X4Q5@QF89,)CNQ^NM2 M"(GE%#KH3*FP@"=AA:EO? K[4*^2P( TWW\T8[I<,(X^Q Y $?YC M),-SA S?=$)(%44I.L45U60TS$;(G ZT24@I%IM,2$1R'N6?$R!Z^N M<1,T-$,!B#&%Q9:@"*A%F@=,95'%8'B>QH3EX*7OJBL-<+#Z()JJ"A0I(*MK M%0QM-:I)ZNYS6LRQ5 P'ANH-H$H4*\DL=S.G2L6)RW]=VAP7P? ?FJ+$.[U^ MK3:KA=9^L]2JD!N0PU2?>@>TS17&#JZ*@X=AEL[063J)6;JDTN76DG:(P#61 MPC+1BEW74376Q5[AC9XJR"WLM9J%O=WF7>WBA90F)F^1@F$Y4N^0Y(I,#MO> MJ]97;8!,A-]+QMHI+>([BNEKFM!&(;+4[$6E1HJM\-L MF'N]A-@W;)[?R.PU4KMO(?1TE+(P:0CN1K?MIDD 2T8L'J, M?C&XMF]EKZG*!6)RE19HH\%4E>=1"(U-\+Q S$']Z\ZG? SBJ%9*U8+RH&'I MW.K@;E #^A)M_CN2F0).P39G,H#@GZH;'S>*R\(.;QJ)?1U,2N":JV"KM] \ MR W"4ZM(QR=_SACMLW@[R'^\<:WS<\^EUZ :NX!?W(!_#')"9A$KT0^@#OC M=";Q(K(_P74LWZL\B/0"A_H:+0H. M1I/]+Z3.C;EP;B0;GALSM2US@LPE)D@"H #(OR&1Z$0162),PN MPHSKR<)RN0&DQ80:OPC$;3B^9<(LNGHU7JB+S)9J#)W#"=R+8[GE6365MI2^ MWOR0V05"!5>(2(T'7FD@;P>;7Y3]1P(LA)2@(.R:.S[4-= 3Z/2IJA_OGY8! MATCD!L.V*7?5^1>T$FSFC/J41^.[C@6QNH$^S2@5B.48-%#W-WSJ@QW\06\H MY]I3 %<< S7.!!^'YR^5UWA2]/^-8XZ$CN=6T._!P.,VRWTH^JCI8'59^HG1 MQ[PPYE.,T M(&(*<6"TU-A?Z)#@(9%IS@F.F*LH1:ZT(EX,55G1#N^)B]X0AR\UW%/12-BG M0JRW*F:2 'T@F@X"']^VZ,W$MW1$J6.PB%)#^0#%!C>1K;0WTD\@(34G@F!( M9E]E5]IV4F=;*Z EL@_HJ 2>/-R5HNY20A\BE1\*\+?^4[KH%-&1*5K^^;EM^ M,.C*DXSZ9!73WG(EU*;VVF]Y/)AWOTUN#Q56>G;).#2@<^ID(FB3SUF'DWC-FW+NNKQ(_R5_=<4R=+CM*OU0NU:?PY MM*+V7%I1VY96W)(MVH!JQ/$T9H/5E3F8:=J<-CR?EVAL7QTV:/[ 3A7H@GA M9FH7!B,GU*/Z=MP=W(ABXI8/# ."<*>GOC=)\(.3Q P^X8";T;=YI. ^:.R6 MK$;]?SN!4?N9P-A^E!C]6E3O=?]X]&ZPT6]3/5^(>Y%8?!/X%5.AHY-[GF8I MI.WM-WUK00SJ2Y72X3*X54[%NA #0L?T>B(N;XP9!-$3S-$B(14I!@5PZO!M MS\DI/3E_G: MAB.+>WQ9YC'Q1LH!7LWM5N7V>X:#8LU[E:HGBCVT;VE-;)"]KQ8'MT&8NX+, MC4J:M\NRK*X^/..S,6;1.E2(KQ'LEIFG9MZPB74F;K"E[X0AZ@QXJD)M$L=. M*8> \D(PJ78[!B$H9Q.8C,)KG<_5M#$P+3%?:6YS<&ER92YH=&WM76M3VTB7_NXJ M_X?>U+M3I$J8.\D0AAH"SH1W&$B!DVQJ:S^TI;;=@RX>M03Q_OI]SNEN63(F M<3(&LC5,U20@M5JGSSG]G&LK^V][?YP>M%O[;[N'Q_A;T'_[O9/>:?=@?\W^ MC;MK[O;^Z_/C3^*R]^FT^\NS0986>V)C?5R(GDZ4$6?J1EQDB4P#>R$0ERK7 M@V=X$(^^^];G7HE$YD.=[@D:NOY*%.ISL2IC/<2E7 ]'Q;.#_=<'W<\CW=<% M)NQL[*^]!MGO[N.%H4H+E3\[^"GMF_&K>WX)EG5T?G;Y_K1WI"H'_2=IV F$%,Y M+'2&1<992!2U6[(0FUMXY0<9QTI%IF5YK$!J(WS^)[?7MS.1!)/!7Z@EF(1M MQ7=T.A10\&L=@A;<N%O'_[D_J;'IA1CR:@39;0V?E'S$5B>G-^T0V$3ED:.E(6YMHM MZ#MQ9YRK!/!C*D5/RJ+$=@BS:Y5"IF"\*DAJQ4B Z0H3T4@2HY7",,LBOG0M MXU+V8]5\D=41B$3IL16>*0<#R!9;<,*0?S/2 '>@&DT/F'Q,2S[+\_6G_'OE^\.C_SOW_G2U2(;\XNK"_VL*++$7;O143&B M^=;_$^Y%[\*_YEJ!&Z&,O:I@ECM@FA9P[!]STWD5@JMX?'#7[>9\L1K ;]OH MS#XR]YW[[P_J!LF003*T;@:(_;7W!QW1NX4K!-;7T"KL:PBXCB -%)\'.5!9 M&@]#+^]"^5LH,V,Z:3Y/H;>A,"<&BOU7J0RC$%328X]H0H_E"[G]/)NO=S\)KVLD,MJXLD,<-8,F->,=LNKAIC:ODH#*B4&9BEZ MM.[\!@U-OH'_!B TI1*5CE>/&WB0BIQD<11+:.HAZ$H2$&2*++P*Q+_6.^OK MZQNPOS)G+%9$C7TL$ [M_9OJ7K2?[LA.=TG35;XKP[V0"1"W$-!U;#&0=G[6 M%6_?GQU?=(_%FY,WO4]\I??V_/WEX1FX?/)?[9:_3Q?.3LZZ&/3FY$-7')^? MGAY>7 HW$)>/$ 5=BI5_;>QL!+L_[W1VU^'(1[1+$VQ*#@V(W##.#.U#^,9A M;6UUCM27(+ =@-P@>#D3)I(_B6.Y%@76 5"BBL8MLQB YXO1)%+-C*1G B= M$#; O8@)8#3)W$J$HA7+S;H:@10$S:+>"/ 4B1B>P#,X0: MD%DU-+,5.D.(BC7VR62.!H (>FFD#!07]HUOSUOYC09UT%1,)%9VGD_1#2LS M;/G59Q66K,YW+J5Z;6R^!K2O)! $2T6!DK"H%FT\/^-&WCD&9)"ZZPF3$ MVFO+Y%0-LT*S/P9@78C2C8<@P^470G'ZR'Y27$>E@WL=/PB6:+-:^S'&<,"U8X#(HD'^OH MU61$QA$6D;3*> 5IOOT55O.%Y;1;"="9"!NIF/S 2 T0>I/"!%A13#J-9R=D MVP4% _DB2Z:-Y!Z^O8C& K OV,F]@8<,/;F6.N;M:V=FM=O8WB8/)"GC(2LO MWW)BG?-J[U?X9RN@K?QI.1[',)+TFEC>!,XO=UO-(4R[11Y1FHFL#R-F:87( M_-KOY">S^TOJ T6%(EC]@<0&Q,= F"S&G[PM<84OC9U_#C3)ISR" V3&F0$; M(&U"H:PLFAR]4R:LY=.EFX)PUDS'@!>&F 2)96/H@(6N$';)J+B&K10_A&I< M\"PSGB*ST92(-F:E3"MVVAIQ- ]&77^53WT%4RNK/0^X;;-,H M-P<0%%J0SW5/ZXD8FQA O&79UU117$^IM!O*LX[TF-'!8H*> M>AMW[(,&D,A MGG@GA^H5GD2<"3[C!:_$.=LKLT=ON+3\>$59ZI)NB]555_/9/S[YX(FK[Y&- MS3F;9)>N];,<:%%=>QW#$1$;G1U0"!N@(U#X;IZ^VA+'0CL14[PY/^O5F;8Z MD(F.)WM?8QN/-?I_E>4R9JJQR3,(SM1DC!&'N>SK\!7<_D19)IYEQ)J-^D-K M_BFZL[]&A+$,]M? NCE<[,/,7*WV%788)AVS9.IKWIVS9N)VG6\UX==UJ?'* M.HE$NI7I$S@_$#AO+PS.9XA9JJ35H85C3@1,L]04 Y8I5L%[UEK[=HM\;8 8 M662@'*=%G4N!^$Y1 @$PS,X\._)1"<=F" ?#9E\1.2KV-WS\"D+**JW?VMM;;K7$GZ8@54J1/ M67XECG0!&P5=>DZ+E(T@-A 4ZM%[4@BF<4O(@?> %UF_F%U^N_7WUL^T$AWL M]#G7LDD]/66#%8Q)>?5BSN(1A56KAS&?67]HUP^W+B-O=3.-FG&^2WVS0:_Q M@E:":Y8-5'V%(_"^<]D1*:^>$A64K,^&*7 6*@PNI%25;[?@:N>:DB[6_K-) M7L%+;3 84YDW(P06=6YKDWE;KN9:D29V725SFL MQXN=%\_%BZWMU9WMW>T'(Z1+R+0GKD*9Y[]JJR_7JN@ G-GDY0.@^-7,G0>C M[K HL'L D'OB=YWTR5(?@5"F[$*'(YE'X@T1N-S]N_6RL['S@V'61P1>,&AA M-IZ(%5N[G6:-*,-;Z*(LX%A8J(>9RI97?KT?KBRZ5PBG<]HKI_)&_)9GY3@0 M[XX>[/W;F\ N]1GFNX#)/02 E+=E$!4#LO&^L:+AP//.:BU MN[W[7+S #VT(@57K'$H^ODU_XH+)1,'@N/ MOJ"6[=9]Z*6+C!B-%MR:3[FQ2G(["^?&>MR_46NEF>G[MEYC3IFBE))A-JG5 M;MFB5^&>GBER$5;3+5,U+LAIXT)735ZZT M8,06?H?+,AR)G]LM*S93YM>TNF(JY#FM)/>?SEFL_?QI_U;[=_=;FN$&FG!1 M2]+N>8V9 7?#C71B5#S@K3/B-OLA=7P$50_QM(6E*H77JI>UO1@(]9F*]P0' MKI7.-];@&9W7]IV9+>Y3ZZ_M+@!)M(/M81*;9*9$.RP.QZ>TM9KM<(%KW(PG MML[H?Z/KAMK.%%-H5)BKPF:,IZS!>)OZY2:,:GD$/[&2>4SLV/%4=:9EKWQLT& !^@!#&BH>VI+>F=4() MSBI*O>,'A(O+B"O#TU605,:YNM99:< 3SX2H*@V7$ ,GOSTBYS)2,TVO56P4[,$KS)_5ZH<$0U MBH:^81D WS2<5<,5*U:?_*=\65HJIL!U!%#3-'/.*9ZR5D]P=2+$EXFH2^H .]Q4MAS7+>I:!=D71B M-93<#@;\(J275"7%=1G!3;$M7_R$*4-HK^&?L0? !,X,V7I'U-',%UP$]'[ MZ$<"1'< !KN*NULH_>L;-7/+,&Y+I)9.B^!\B 4;8G92^CM2%2%UHN 26D+J M,!;4D*Y&-W> C[(XXGJ*A +"SDP()>FD#5ULMZQ-L^MU2[S%))6,XVS"?+3' M;N#EV2GMV2"=>UPFU^^V&!9A,O6F?8U:L0BQ7 >O$6S$#1"9_O8<)S^ULK!^ M,6*%ZBW04V\BG8I'7)&:>+M(SX<9(SQ>1Z[ O.%Z>AJ$6^Q9,:B+E%X=QA** M"X<=Z$&FA.,+]M1M;S/V""BG3JVHBB&T&X 57&F*1.!/F(P4C4Z&*C8]M$]2 MV\/*/P9N$\WX^:R=(SH9BD'L@+#59$^$G!,YA+4U,VVESJPV>1+4NC9M&Z:E M\,\RUR;2;C$-KX9%0,W%655WKW5UDXV@GZB*3$8#?V:POY.:V0RHX)R2N<$< M(3>MI:[H; TP+%U!7*DL75 %<*J!>6FRLMZ78( M\S:J1@H:S-5IY_ 3/"+TXBFL*C. MT;1/4=WRJ!$[-V%_X4W8A=#SFIVT&W&F$%;%_C8,4_P, MI9K\ /\M$Q>%3=OIX2<@YE=1TWOPN6W*2Q44B5+^((>3,O1G57,;\AJX*!1; MFNJ[4K,Q5M$\N6O=FRGESMGPQXOK94?$<>Y3*[XX<>=Z[%=-GO3\A]/S<&$] M)Q4I\I)-2$>0EO>^G .8GA,)[:.J@:X1?YDA#!&5JH'W]M++;))ZI2Q#JT1[8Q7:?=.JQ\:2..W3L")I3F?_* MXNP7 9+$?HM+?0[CTG"NS9^K]T=7J=Q0<%S !HX_Z#(]*4%?IJ@>X4,CQ*9; M2[<[T^=I?!W0,:!Z>S9Z.AA6OD)(X.J%,'$@;B01PVM32\ AV"ER^F0-?3H)G"\3O(L+F] MTKF^[)Q?BXN2WMSW1.Q>'HG=QD)4'XX0(D6]UZKW/I< MDUGML+ZV7\YRWVR(J.I:YE7_B3VU:\_8-DZAU5VN.2E'][&PJH#^S=4!Z[JZ MJL"3)OYPFJ@6UL2WBC^;4^DAR=Y>(0 UOHG(?SPN5[[I +IHLI@ ?V![*BR" M^0^IT,Y!/)?\W&3A1,?#SIG74O+P5_D/?\S^; &?>?VY9=&V:>[;^V=Y._'U0;-X9C\=[S94[_A.PG;)KGL^DV4E M4_)=*[U%4VW6:O!R7O4UF+Q75J^9-7'4$6\[S9-1-Z51E@P M9U=[NJXOM70#SS8GU^"93(&Q^[,>&#>(O)^(;XW^_3%.4E4I M*9O:.JM*,O/KYRR9M6A#W :/;>P'+*JR,D^>_7QY2G3>]SY<'#4;G??=XS/X M7^"_3N^\=]$]ZFSQ_W!WR][NG%R=?1:WO<\7W=_7!G&4'8CM=I*)G@Y5*B[5 M1-S$H8Q:?*$E;I71@S5X$!Z]?NQSAR*49JBC X%#VXCC* M["4=^0JG;&_NZVCMJ'-RU/TRTGV=P2*;.YVM$]C*]7,0X<&RRLRGXM>HGR:' M_P\+P_;?=2^[-\<7XJ9[T3V^[8KC=S?=[H?N9>\9>?%GGF9Z<#]%T^YO2?;, MO%BV<&^D4W$\-$J%<%7X,E.^D*F(!\U&-E+B=>?VC^NC;-39PO_A_CW<$A^D M\49BI[VS)]9QU*^!_U<>'[Y3D3(R$#*C C'I2)I[<2U-!L_#ELXC;[,E)&QV+'W9;'BQ26(C,QW#MH/88R(S\:8M M+NZC:"3',",\?C>1]\"07&=*[+7;+?%1(U.T%"=*>J/*[SN[>_L[-=I/XS"1 MT;VC5,C(%^OZE7AGU# &ZHY-F&8FCH:M9F-=PXU_JRA2V0CX#S\N\@B>TVG6 M$F. M/KWOWH =MX11 V54Y"D!:AU*7XDL!C: KGC*9%)'CA\?9 J*UVQ,JZBU@+>J M;W)4RNU_ME#/MVNZP@_/JK?HWY,H90AZ0MRW6L6B*&1 @_[]\51JRN6BN'E.-ZU<6E:H5UX6]^'^SC;)=*M!Y9S;- MQD2G(V03,#(+%#T+S(N#,7P. I'$*$TM Y0"*4)+Q 9OJ2'(U0ND#H%HG:8Y M[ ;NH*W Q2B#JY.10JE 4 -_BVH ]RL6]-QI]%PGQPW?IY@9N#'Z!R U2"7"*-P;!W! M/.LO#&3::;'*@:PH@^49R8/ I84)E@"EA) /;BD6YS08P!OF5&!5"GEBZTS#/Q,<0K-A5):;B"2*S"D%C^P"&V;U *%B

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�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

XML 17 ea0201326-8k_inspire_htm.xml IDEA: XBRL DOCUMENT 0001939365 2024-03-06 2024-03-06 iso4217:USD shares iso4217:USD shares false 0001939365 8-K 2024-03-06 INSPIRE VETERINARY PARTNERS, INC. NV 001-41792 85-4359258 780 Lynnhaven Parkway, Suite 400 Virginia Beach VA 23452 757 734-5464 false false false false Class A Common Stock, par value $0.0001 IVP NASDAQ true false